ALB and membranous glomerulonephritis: The GN-risk-score is a web-based tool, proposed by the KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases, designed to assess risk of TE versus risk of bleeding events in patients with membranous glomerulonephritis treated with warfarin with an INR 2–3 dependent on plasma-albumin level [9].